Large Shareholding Report Filed (Including Acquisition Price Correction)


  • Filed large shareholding report (general form)
  • Correction of acquisition price: calculated based on closing price of 4,515 KRW on Dec 30, 2025
  • Specific number of shares, ratios, and reasons for change not disclosed
  • Unable to determine positive or negative impact (neutral)

KOSPI Filing Information


  • Filing: Report on Large Shareholding (General)
  • Company: Yuyu Pharma (000220)
  • Submission: Yoo Won-sang
  • Receipt: 02-03-2026